RHONDA STAMEY: Open Payments
NPI 1487174165 · JEFFERSONVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$13,703 in 173 payments from 21 companies in 2025. Trend: 2023 $3,774 · 2024 $7,459 · 2025 $13,703
Speaker / faculty: $7,225Food & beverage: $3,955Consulting: $1,320Travel & lodging: $1,100Education: $103
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 31 | $10,169 |
| PFIZER INC. | 27 | $445 |
| Ferring Pharmaceuticals Inc. | 4 | $385 |
| Sumitomo Pharma America, Inc. | 19 | $363 |
| Medtronic, Inc. | 3 | $320 |
| Novartis Pharmaceuticals Corporation | 15 | $311 |
| Merck Sharp & Dohme LLC | 10 | $292 |
| Bayer Healthcare Pharmaceuticals Inc. | 16 | $265 |
| Janssen Scientific Affairs, LLC | 2 | $243 |
| ACCORD HEALTHCARE, INC. | 21 | $196 |
Products named: RYBREVANT, ERLEADA, XTANDI, ADSTILADRIN, ORGOVYX, INTERSTIM, PLUVICTO, Camcevi.
Industry payments across IN — which companies pay providers there.
